Scott Gettinger
MD
Associate Professor, Medical Oncology
👥Biography 个人简介
Scott Gettinger is a thoracic oncologist at Yale who has contributed to elucidating the mechanisms of synergy between anti-PD-1 and anti-CTLA-4 agents, including the role of Treg depletion within tumors by CTLA-4 blockade. His translational studies have analyzed the immune contexture of NSCLC tumors in relation to combination immunotherapy response and characterized genomic features associated with response versus resistance. He participated in early CheckMate trials of nivolumab plus ipilimumab in NSCLC and has led Yale-based immunotherapy trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Scott Gettinger 的研究动态
Follow Scott Gettinger's research updates
留下邮箱，当我们发布与 Scott Gettinger（Yale Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment